Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Miguel A. Gassull"'
Autor:
Eduard Cabr??, Miguel A. Gassull
Publikováno v:
Current Opinion in Clinical Nutrition and Metabolic Care. 6:569-576
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::eb40e5e9f5e07fdc3b95e596155e788a
https://doi.org/10.1097/00075197-200309000-00011
https://doi.org/10.1097/00075197-200309000-00011
Autor:
Miguel A. Gassull, Eduard Cabré
Publikováno v:
Current Opinion in Clinical Nutrition and Metabolic Care. 3:345-354
In the last year some relevant papers on nutrition and metabolism in chronic liver disease and transplantation have been published. Studies investigating the reliability of predicting energy expenditure in cirrhosis, and some relevant contributions t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ac9bdfe212c8c93435873ca4d2eac277
https://doi.org/10.1097/00075197-200009000-00004
https://doi.org/10.1097/00075197-200009000-00004
Autor:
Albert Pardo, Eduard Cabré, Joan Riba, Justiniano Santos, Belén Viñado, Ramon Planas, Teresa Luque, Ramon Bartolí, Vicenç Ausina, Vicente Lorenzo-Zúñiga, Miguel Angel Gassull
Publikováno v:
Hepatology. 31:858-863
Deranged intestinal motility, which occurs in cirrhosis, may facilitate the development of intestinal bacterial overgrowth (IBO), which can lead to bacterial translocation (BT). To assess the effect of cisapride on IBO and BT in cirrhosis, cirrhotic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::85f5e0bd22b23e78b895ae7a54e13322
https://doi.org/10.1053/he.2000.5746
https://doi.org/10.1053/he.2000.5746
Autor:
Jose C. Perales, Ester Rodriguez, Miguel Chillón, Carolina Romero, Adolfo Río, Assumpció Bosch, Miguel Angel Gassull, Laura Planells, Ester Fernández, Hirofumi Hamada, Marta Miralles, Aida Raventós, Joan F. Burgueño
Publikováno v:
Human gene therapy methods. 24(4)
The lack of vectors for selective gene delivery to the intestine has hampered the development of gene therapy strategies for intestinal diseases. We hypothesized that chimeric adenoviruses of Ad5 (species C) displaying proteins of the naturally enter
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dd1f208dd2c905132a3e0b9985c3c577
https://pubmed.ncbi.nlm.nih.gov/23746215
https://pubmed.ncbi.nlm.nih.gov/23746215
Autor:
Ramon Eritja, Sandra M. Ocampo, Ester Fernández, Joan F. Burgueño, Carolina Romero, Jordi Bermúdez, Jose C. Perales, Anna Aviñó, Miguel Angel Gassull
Publikováno v:
Digital.CSIC. Repositorio Institucional del CSIC
instname
instname
Tumor necrosis factor (TNFα) is a proinflammatory cytokine involved in the pathogenesis of inflammatory bowel disease (IBD). Although TNFα has been extensively targeted using systemic drugs, the use of antisense and small interfering RNA (siRNA) to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8fb252021bcfa1e99de0275f08239d44
http://hdl.handle.net/10261/51485
http://hdl.handle.net/10261/51485
Autor:
Miguel Angel Gassull, Xavier Forns, Jose María Llovet, M. Navasa, Antonio Follo, Antoni Rimola, Ramon Planas, Joan Rodés, Vicente Arroyo, Anna Francitorra
Publikováno v:
Scopus-Elsevier
Although spontaneous bacterial peritonitis is considered a precipitating factor of renal impairment in cirrhosis, no study specifically addressing this problem has been reported. This study was aimed at assessing the incidence, clinical course, predi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::13d05723e9a965c8d8bed16e4b9f50f4
https://doi.org/10.1002/hep.1840200619
https://doi.org/10.1002/hep.1840200619
Autor:
José L. Periago, F. Sanchez-Medina, Esteve-Comas M, Juana González, Angel Gil, Ferrán González-Huix, Ramon Planas, Fernando Fernández-Bañares, Miguel Angel Gassull, A Abad-Lacruz, Eduard Cabré
Publikováno v:
Journal of Parenteral and Enteral Nutrition. 16:359-363
Fatty acid levels (from C14:0 to C22:6n3) in plasma lipid fractions were prospectively studied in 11 cirrhotic patients with chronic hepatic encephalopathy and compared with those in 23 cirrhotic patients without chronic hepatic encephalopathy with s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::65877d96fa32f5a509d030a209b4ce50
https://doi.org/10.1177/0148607192016004359
https://doi.org/10.1177/0148607192016004359
Autor:
Andrew Lyne, Mary Palmen, Michael A. Kamm, Stefan Schreiber, Lechoslaw Jackowski, Todd Butler, Miguel A. Gassull, William J. Sandborn, David Stephenson, R Joseph
Publikováno v:
Gastroenterology. 132(1)
Background & Aims: SPD476 (LIALDA™ in the US; MEZAVANT™ in the EU; otherwise known as MMX mesalamine; Shire Pharmaceuticals Inc., Wayne, PA, under license from Giuliani SpA, Milan, Italy) is a novel, once-daily, high-strength (1.2 g/tablet) formu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cc84f04e1ca776c8af6bc4d89195380a
https://pubmed.ncbi.nlm.nih.gov/20877185
https://pubmed.ncbi.nlm.nih.gov/20877185
Autor:
Nivardo Rodriguez, Joan Saló, Juan Rodés, Pere Ginès, Angels Ginès, Miguel Angel Gassull, Vicente Arroyo, Angelo Gatta, Francesco Salerno, Eugeni Domènech, Carlos Guarner, Ramon Planas, Paolo Angeli, Germán Soriano, Luis Anibarro
Publikováno v:
ResearcherID
It has recently been suggested that insertion of a titanium tip at the venous end of the LeVeen shunt drastically reduces the rate of shunt obstruction. To assess whether the LeVeen shunt with titanium tip improves the results obtained with therapeut
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b5c008ab3d8233ccffecbca7a37d6b9d
http://hdl.handle.net/11577/143134
http://hdl.handle.net/11577/143134